Croda International Plc (LON:CRDA – Get Free Report) insider Tom Brophy purchased 5 shares of the business’s stock in a transaction that occurred on Monday, August 10th. The stock was bought at an average cost of GBX 3,292 per share, for a total transaction of £164.60.
Croda International Trading Up 0.5%
LON CRDA opened at GBX 3,285 on Friday. The company has a market capitalization of £4.58 billion, a price-to-earnings ratio of 57.73, a price-to-earnings-growth ratio of 1.40 and a beta of 0.92. The company has a debt-to-equity ratio of 36.06, a current ratio of 2.57 and a quick ratio of 2.25. Croda International Plc has a 12 month low of GBX 2,437 and a 12 month high of GBX 3,352. The company’s fifty day moving average price is GBX 3,060.22 and its two-hundred day moving average price is GBX 2,946.12.
Croda International (LON:CRDA – Get Free Report) last released its earnings results on Tuesday, July 28th. The company reported GBX 72.20 earnings per share for the quarter. Croda International had a net margin of 4.61% and a return on equity of 3.65%. As a group, research analysts predict that Croda International Plc will post 181.8307268 earnings per share for the current fiscal year.
Analysts Set New Price Targets
Read Our Latest Report on CRDA
About Croda International
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.
Recommended Stories
- Five stocks we like better than Croda International
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.
